| P2093 | author name string | M Constenla | |
| | J Feliu | |
| | J de Castro | |
| | M González Barón | |
| | J Dorta | |
| | J Belón | |
| | J M Vicent | |
| | L López Gómez | |
| | M A Jaraiz | |
| | M P López Alvarez | |
| P2860 | cites work | Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial | Q29547565 |
| | Reporting results of cancer treatment | Q29620070 |
| | Phase I-II study of gemcitabine and fluorouracil as a continuous infusion in patients with pancreatic cancer | Q33328191 |
| | Phase II trial of gemcitabine (2,2'-difluorodeoxycytidine) in patients with adenocarcinoma of the pancreas | Q33491184 |
| | Phase II trial of paclitaxel and granulocyte colony-stimulating factor in patients with pancreatic carcinoma: a Southwest Oncology Group study | Q33499593 |
| | Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer | Q34063503 |
| | Treatment of advanced pancreatic cancer with 5-fluorouracil, folinic acid and interferon alpha-2A: results of a phase II trial | Q36079872 |
| | A phase II study of continuous-infusion 5-fluorouracil with cisplatin and epirubicin in inoperable pancreatic cancer | Q36135201 |
| | Report on nationwide pooled data and cohort investigation in UFT phase II study. | Q36433925 |
| | No standard treatment is available for advanced pancreatic cancer. | Q40466201 |
| | Cancer statistics, 1999. | Q40817780 |
| | Saturation of 2',2'-difluorodeoxycytidine 5'-triphosphate accumulation by mononuclear cells during a phase I trial of gemcitabine | Q41166747 |
| | Chemotherapy prolongs survival in inoperable pancreatic carcinoma. | Q51133785 |
| | Lack of efficacy of high-dose leucovorin and fluorouracil in patients with advanced pancreatic adenocarcinoma | Q67948179 |
| | Fluorouracil and high-dose leucovorin in previously untreated patients with advanced adenocarcinoma of the pancreas: results of a phase II trial | Q68072141 |
| | Plasma and tumor tissue pharmacology of high-dose intravenous leucovorin calcium in combination with fluorouracil in patients with advanced colorectal carcinoma | Q68095621 |
| | Continuous 5-fluorouracil (5FU) infusion in carcinoma of the pancreas: a phase II study | Q68271930 |
| | One-sample multiple testing procedure for phase II clinical trials | Q70365924 |
| | Efficacy of oral tegafur modulation by uracil and leucovorin in advanced colorectal cancer. A phase II study | Q71127386 |
| | A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer | Q71528572 |
| | Phase II trial of topotecan in advanced or metastatic adenocarcinoma of the pancreas | Q71574198 |
| | Phase II trials of 5-fluorouracil and leucovorin in patients with metastatic gastric or pancreatic carcinoma | Q71760913 |
| | Should further studies of chemotherapy be carried out in pancreatic cancer? | Q72084799 |
| | Phase II trial of CPT-11 in patients with advanced pancreatic cancer, an EORTC early clinical trials group study | Q72327076 |
| | A phase II survival comparison of patients with adenocarcinoma of the pancreas treated with 5-fluorouracil and calcium leucovorin versus a matched tumor registry control population | Q72848532 |
| | Practical recommendations for the management of adenocarcinoma of the pancreas | Q78023541 |
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | phase II clinical trial | Q42824440 |
| P304 | page(s) | 1706-1713 | |
| P577 | publication date | 2000-10-01 | |
| P1433 | published in | Cancer | Q326041 |
| P1476 | title | Phase II trial of gemcitabine and UFT modulated by leucovorin in patients with advanced pancreatic carcinoma. The ONCOPAZ Cooperative Group | |
| P478 | volume | 89 | |